Glucose tolerance impaired – Diagnostics – Overview of Information and Clinical Research

Understanding how impaired glucose tolerance is identified can help you take control of your health before it progresses to something more serious. The testing process is straightforward, and knowing what to expect can ease any concerns you might have about getting checked.

Introduction: Who Should Be Tested and When

Not everyone needs to be tested for impaired glucose tolerance, but knowing whether you’re at risk is an important first step in protecting your long-term health. If you fall into certain groups, getting tested becomes more important than waiting for symptoms to appear, because this condition usually doesn’t announce itself with obvious warning signs.^[1]

You should consider getting tested if you have a family history of diabetes, especially if a parent or sibling has been diagnosed with type 2 diabetes. Your body mass index also plays a role—if it’s greater than 25 kilograms per square meter, your risk increases. A sedentary lifestyle, meaning you exercise fewer than three times per week, is another factor that should prompt you to seek testing.^[1]

Other health conditions can signal the need for testing as well. If you have high blood pressure or problems with your cholesterol levels, these issues often go hand in hand with glucose problems. Women who have experienced gestational diabetes—which is diabetes that occurs during pregnancy—or who gave birth to a baby weighing more than nine pounds should also be screened. Additionally, women with polycystic ovary syndrome, a hormonal disorder, face higher risk.^[1]

Your ethnic background matters too. People who are Black, Latin American, Native American, Asian-Pacific Islander, Middle Eastern, South Asian, Pacific Islander, or North African have a greater likelihood of developing glucose intolerance and should be screened more carefully.^[1]

The American Diabetes Association recommends that most adults begin screening at age 35. However, if you’re younger than 35 but are overweight and have additional risk factors, you should be tested earlier. If you’ve had gestational diabetes in the past, your healthcare provider will likely check your blood sugar levels at least once every three years.^[13]

⚠️ Important

Impaired glucose tolerance usually has no symptoms, so you can have this condition for years without realizing it. This is why screening based on risk factors is so important—you cannot rely on how you feel to know if you need testing. Many people only discover they have glucose problems when they undergo routine medical checkups or screening tests.^[2]

Classic Diagnostic Methods

Several blood tests can identify impaired glucose tolerance, and each one measures your blood sugar in a slightly different way. These tests help doctors determine whether your glucose levels are normal, elevated but not yet diabetic, or high enough to diagnose diabetes. Understanding what each test does and what the results mean can help you prepare for your appointment and make sense of your results.^[5]

Fasting Plasma Glucose Test

The fasting plasma glucose test is one of the most common and straightforward ways to check for glucose problems. This test requires you to avoid eating or drinking anything except water for at least eight hours before your blood is drawn, which is why it’s typically done first thing in the morning. After you’ve fasted, a healthcare professional takes a blood sample from your arm and sends it to a laboratory for analysis.^[1]

The results are measured in milligrams of sugar per deciliter of blood. If your fasting glucose level comes back below 100 mg/dL, that’s considered normal. If your result falls between 100 and 125 mg/dL, you have impaired fasting glucose, which is one form of glucose intolerance. A result of 126 mg/dL or higher on two separate tests indicates diabetes.^[1]

Because this test only requires a simple blood draw after an overnight fast, it’s convenient and widely available. However, it only captures your glucose level at one moment in time, and doesn’t show how your body responds to sugar intake.^[13]

Oral Glucose Tolerance Test

The oral glucose tolerance test provides more detailed information about how your body handles sugar over time. This test is particularly useful for diagnosing impaired glucose tolerance, which refers specifically to how your body responds after consuming glucose. The test begins with a fasting blood sample, similar to the fasting plasma glucose test.^[3]

After the initial blood draw, you drink a sweet liquid containing a specific amount of glucose—usually 75 grams for adults. The liquid tastes similar to very sweet soda. Your blood is then drawn again at specific intervals, most commonly at the two-hour mark, although some tests may include additional measurements at 30, 60, or 90 minutes.^[9]

The two-hour measurement is the key number doctors use to make a diagnosis. If your blood glucose level at two hours is below 140 mg/dL, that’s normal. A reading between 140 and 199 mg/dL means you have impaired glucose tolerance. A level of 200 mg/dL or higher suggests diabetes.^[4]

Some people experience side effects during this test. You might feel nauseated, sweaty, lightheaded, or short of breath after drinking the glucose solution. These symptoms are more likely if you’ve had similar reactions during blood tests or medical procedures in the past. If you have a history of such reactions, let your healthcare provider know beforehand.^[9]

While the oral glucose tolerance test provides valuable information, it’s less commonly used than other tests in routine screening because it takes more time—up to three hours in some cases. However, it’s particularly useful when other test results are unclear or when doctors need to confirm a diagnosis. This test is also the standard approach for detecting gestational diabetes during pregnancy.^[3]

Glycated Hemoglobin (A1C) Test

The A1C test offers a different perspective on your blood sugar by measuring your average glucose levels over the past two to three months. This test works by measuring how much sugar has attached itself to the hemoglobin in your red blood cells. Because red blood cells live for about three months, this test provides a longer-term view of your glucose control rather than just a snapshot of one moment.^[5]

One major advantage of the A1C test is that you don’t need to fast before having your blood drawn, which makes it more convenient than the other tests. The results are reported as a percentage. A result below 5.7% is normal. If your A1C falls between 5.7% and 6.4%, you have prediabetes, which includes both impaired glucose tolerance and impaired fasting glucose. An A1C of 6.5% or higher on two separate tests indicates diabetes.^[5]

However, the A1C test isn’t perfect for everyone. Certain conditions can make the results inaccurate, such as pregnancy or having an uncommon form of hemoglobin. In these cases, your doctor will need to use one of the other testing methods instead.^[13]

Understanding the Relationship Between Tests

It’s important to understand that impaired fasting glucose and impaired glucose tolerance are actually two different conditions, though they’re often grouped together under the term “prediabetes” or “glucose intolerance.” They measure different aspects of how your body handles sugar. Impaired fasting glucose indicates a problem with your baseline glucose level when you haven’t eaten, while impaired glucose tolerance shows difficulty processing glucose after you’ve consumed it.^[1]

Interestingly, these conditions don’t always occur together. Among people who have one or both conditions, research shows that only 16 percent have both impaired fasting glucose and impaired glucose tolerance, while 23 percent have impaired fasting glucose alone, and 60 percent have only impaired glucose tolerance. This means the conditions are metabolically distinct, with limited overlap.^[1]

Your doctor may order more than one type of test to get a complete picture of your glucose metabolism. If one test shows elevated results, a second test done on a different day is often needed to confirm the diagnosis. If you have classic symptoms of high blood glucose along with one very high test result, your doctor might not require a second test.^[5]

Diagnostic Testing for Clinical Trial Qualification

When researchers conduct clinical trials to study new treatments or prevention strategies for diabetes, they need to carefully select participants who meet specific criteria. The diagnostic tests used to qualify patients for these studies follow standardized protocols to ensure that all participants truly have the condition being studied and that results can be compared reliably across different research sites.^[12]

Clinical trials focusing on impaired glucose tolerance or impaired fasting glucose typically use the same diagnostic tests that doctors use in regular practice—the fasting plasma glucose test, the oral glucose tolerance test, and the A1C test. However, the way these tests are performed and interpreted in research settings may be more rigorous than in routine clinical care. Trial protocols often require multiple measurements to confirm that a person consistently meets the diagnostic criteria, reducing the chance that someone with temporarily elevated glucose levels is included.^[12]

One important consideration in clinical trials is the reliability of the diagnosis. Blood glucose levels can vary from day to day due to many factors, including what you ate recently, your activity level, stress, illness, or even just normal biological variation. Because of this variability, clinical trials often require confirmation testing on at least two separate occasions before accepting someone as a participant. This helps ensure that the glucose intolerance is persistent rather than a one-time fluctuation.^[12]

Clinical trials may also use specific cutoff values that differ slightly from those used in general practice, depending on the research question being studied. For example, some trials might focus only on people with both impaired fasting glucose and impaired glucose tolerance, while others might include anyone with either condition. The eligibility criteria help researchers study specific populations and answer targeted questions about prevention or treatment.^[7]

Beyond the basic glucose tests, clinical trials often collect additional information to better characterize participants and identify factors that might affect outcomes. This can include measurements of weight, waist circumference, blood pressure, cholesterol levels, and other markers of cardiovascular health. Some studies also assess insulin levels or perform more specialized tests to understand how the body is producing and responding to insulin. These additional measurements help researchers understand not just whether someone has glucose intolerance, but also what other health issues they face and how likely they are to progress to diabetes.^[1]

The standardized diagnostic criteria used in clinical trials have been established through collaboration among major health organizations, including the American Diabetes Association and the World Health Organization. These standards ensure that when researchers report findings from their studies, other scientists and healthcare providers can understand exactly who was included and can compare results across different trials. This consistency is crucial for building a solid evidence base about what works to prevent or treat glucose intolerance.^[2]

⚠️ Important

If you’re considering participating in a clinical trial for impaired glucose tolerance, you should expect to undergo thorough testing even if you’ve already been diagnosed by your regular doctor. This isn’t because researchers doubt your diagnosis, but because scientific studies require standardized, documented proof that each participant meets the exact entry criteria. The testing you undergo as part of trial screening will be provided at no cost to you.^[12]

Prognosis and Survival Rate

Prognosis

The outlook for people diagnosed with impaired glucose tolerance depends largely on the actions they take after diagnosis. Without lifestyle changes, approximately one in three people with impaired glucose tolerance or impaired fasting glucose will develop type 2 diabetes within a relatively short timeframe. Research shows that the yearly conversion rate from prediabetes to diabetes ranges between 5% and 10%, with the higher rate seen in people with impaired fasting glucose.^[2]^[8]

However, this progression is not inevitable. Studies have demonstrated that people with impaired glucose tolerance who make significant lifestyle changes can reduce their risk of developing diabetes by 58% compared to those who don’t make changes. Even medication, while not as effective as lifestyle modification, can reduce the risk by about 31%. This means the prognosis is largely within a person’s control—those who lose 5 to 7 percent of their body weight and engage in moderate physical activity for at least 150 minutes per week substantially improve their chances of avoiding diabetes altogether.^[1]^[10]

The risk of developing diabetes varies among individuals with impaired glucose tolerance. Several factors increase the likelihood of progression, including elevated fasting glucose levels, higher two-hour postchallenge glucose values, and having a body mass index greater than 27 kilograms per square meter. People with both impaired fasting glucose and impaired glucose tolerance face higher risk than those with just one condition. Analysis of six prospective studies found that the risk of developing diabetes was approximately 3.6 to 8.7 percent per year in patients with impaired glucose tolerance.^[1]

Even before diabetes develops, people with impaired glucose tolerance face increased health risks. They have substantially greater risk of developing cardiovascular disease compared to people with normal glucose levels. Some research suggests that the long-term damage to blood vessels, heart, and kidneys may already be starting during the prediabetes stage. The condition has also been linked to “silent” heart attacks, which have such mild symptoms that people may not realize they’ve occurred.^[1]^[23]

On a positive note, impaired glucose tolerance is often reversible. Many people who implement lifestyle changes see their glucose levels return to normal. This represents a critical window of opportunity—the condition serves as an early warning system that allows for intervention before permanent damage occurs or before the more serious diagnosis of diabetes is made. Those who take advantage of this window can potentially avoid the serious complications associated with diabetes, including damage to the eyes, kidneys, nerves, and blood vessels.^[8]^[17]

Survival Rate

Survival rate information specifically for impaired glucose tolerance is not typically reported in the same way it might be for cancer or other life-threatening diseases, because glucose intolerance itself is not immediately life-threatening. However, the condition does have important implications for long-term health and longevity. People with impaired glucose tolerance have approximately 1.7 times higher mortality rates from cardiovascular disease compared to those with normal glucose levels, reflecting the serious impact this condition can have on heart health even before diabetes develops.^[2]

The more relevant consideration is what happens when impaired glucose tolerance progresses to type 2 diabetes, which does significantly affect mortality. People with diabetes have a 1.7 times higher rate of dying from cardiovascular disease than people without diabetes. This underscores why preventing the progression from glucose intolerance to diabetes is so important for long-term survival and quality of life.^[1]

From a global health perspective, the prevalence of glucose intolerance and its progression to diabetes represents a major concern. In 2010, the worldwide prevalence of glucose intolerance was approximately 8 percent. Without effective prevention efforts, this number is expected to grow substantially. The progression from prediabetes to diabetes contributes to an epidemic that is projected to affect 86.6 million adults in the United States by 2050—more than four times the current prevalence. This highlights that while individual prognosis can be quite good with proper intervention, the population-level trends are concerning.^[2]

#1 Clinical Trials Search in Europe